RAYMOND JAMES & ASSOCIATES - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,255,588
-65.4%
150,190
+2.9%
0.00%
-66.7%
Q2 2023$3,626,988
+42.8%
146,014
-13.5%
0.00%
+50.0%
Q1 2023$2,539,399
+17.8%
168,843
-7.3%
0.00%0.0%
Q4 2022$2,155,580
+87.6%
182,213
-6.1%
0.00%
+100.0%
Q3 2022$1,149,000
+53.0%
194,138
+9.9%
0.00%0.0%
Q2 2022$751,000
-52.4%
176,644
+6.4%
0.00%0.0%
Q1 2022$1,579,000
-47.8%
165,994
+4.3%
0.00%
-50.0%
Q4 2021$3,024,000
-49.4%
159,134
-11.4%
0.00%
-60.0%
Q3 2021$5,981,000
-21.0%
179,705
-8.0%
0.01%
-28.6%
Q2 2021$7,574,000
-23.3%
195,267
-4.7%
0.01%
-30.0%
Q1 2021$9,881,000
-10.4%
204,992
-10.3%
0.01%
-16.7%
Q4 2020$11,032,000
+90.8%
228,521
+5.8%
0.01%
+71.4%
Q3 2020$5,783,000
+24.0%
216,095
-9.8%
0.01%
+16.7%
Q2 2020$4,665,000
+73.3%
239,482
-12.5%
0.01%
+50.0%
Q1 2020$2,692,000
-24.6%
273,567
-14.9%
0.00%
-20.0%
Q4 2019$3,570,000
+91.1%
321,632
-3.3%
0.01%
+66.7%
Q3 2019$1,868,000
-31.0%
332,649
+6.3%
0.00%
-25.0%
Q2 2019$2,708,000
-11.7%
313,020
-17.9%
0.00%
-20.0%
Q1 2019$3,067,000
+126.7%
381,437
+15.6%
0.01%
+150.0%
Q4 2018$1,353,000
+3.4%
330,019
+41.3%
0.00%0.0%
Q3 2018$1,308,000
-8.1%
233,634
+115.8%
0.00%0.0%
Q2 2018$1,424,000
-55.6%
108,282
-52.1%
0.00%
-66.7%
Q1 2018$3,209,000
+85.0%
226,017
+6.8%
0.01%
+100.0%
Q4 2017$1,735,000
+64.1%
211,595
+137.2%
0.00%
+50.0%
Q3 2017$1,057,000
+26.0%
89,195
+6.8%
0.00%0.0%
Q2 2017$839,000
-31.9%
83,508
-21.0%
0.00%
-33.3%
Q1 2017$1,232,000
+407.0%
105,762
+102.1%
0.00%
+200.0%
Q4 2016$243,000
+32.8%
52,320
+121.6%
0.00%
Q3 2016$183,000
+96.8%
23,612
+53.3%
0.00%
Q2 2016$93,000
-20.5%
15,400
+12.3%
0.00%
Q1 2016$117,000
-59.5%
13,719
-21.2%
0.00%
-100.0%
Q2 2015$289,000
-2.0%
17,413
-8.7%
0.00%0.0%
Q1 2015$295,00019,0750.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders